Elekta AB (publ).

Elekta AB (publ) is a leading global medical technology company that specializes in developing innovative solutions for cancer care and brain disorders. Founded in 1972, Elekta has established itself as a pioneer in the field of radiation therapy, providing advanced treatment systems and software that enhance precision and efficiency in patient care.

The company’s core mission is to improve the quality of life for patients by delivering cutting-edge technologies that enable healthcare professionals to provide personalized treatment plans. Elekta’s product portfolio includes linear accelerators, brachytherapy systems, and software solutions that support clinical workflows and data management.

With a strong commitment to research and development, Elekta invests significantly in innovation to stay at the forefront of medical technology. The company collaborates with leading academic institutions and healthcare providers to advance the science of oncology and neurosurgery.

Elekta operates in over 120 countries, serving a diverse range of healthcare facilities, from small clinics to large hospitals. The company’s global presence allows it to understand and address the unique challenges faced by healthcare providers in different regions.

In addition to its technological advancements, Elekta is dedicated to sustainability and corporate responsibility. The company strives to minimize its environmental impact and contribute positively to the communities it serves.

As a publicly traded company, Elekta AB (publ) is committed to transparency and accountability, ensuring that stakeholders are informed about its performance and strategic direction.

Key Highlights:

• Founded: 1972
• Headquarters: Stockholm, Sweden
• Global Reach: Operations in over 120 countries
• Core Focus: Cancer care and brain disorder treatments
• Commitment to Innovation: Significant investment in R&D
• Sustainability: Focus on minimizing environmental impact